Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • XLB vs MRNA✓SelectedUSD · MRNAXLB vs MRNA performance historyLatest closeAs of-2.19%11/20
Stock and ETF performance explorer

XLB vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+20.7%
MRNA return
-27.3%
Excess return
+48.0%
Maximum drawdown
-24.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-2.2%-2.2%0.0%-2.1%
7D-7.4%-12.7%+5.3%-6.9%
30D-5.8%-20.7%+14.9%-5.0%
3M-7.4%+46.3%-53.6%-9.2%
6M-2.0%+305.2%-307.2%-12.9%
YTD+8.0%+561.2%-553.3%-9.4%
1Y+16.5%+772.1%-755.6%-5.0%
3Y+27.3%+147.0%-119.6%+11.9%
All+20.7%-27.3%+48.0%+9.6%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling